Summary
"Beside Bacteria and fungi, Archaea, the ""third domain of life"" have been described as a stable component of the human microbiome. Yet, only few archaea have so far been isolated from humans.
The project aims to demonstrate that a fundamentally new product, derived from archaea, revolutionizing current standards of treatments for human health, can be developed from our initial breakthrough achievement, the cultivation of these archaea. The benefits of using archaea derived from human bodies, promise a sustainable, safe and beneficial treatment in the future."
The project aims to demonstrate that a fundamentally new product, derived from archaea, revolutionizing current standards of treatments for human health, can be developed from our initial breakthrough achievement, the cultivation of these archaea. The benefits of using archaea derived from human bodies, promise a sustainable, safe and beneficial treatment in the future."
Unfold all
/
Fold all
More information & hyperlinks
| Web resources: | https://cordis.europa.eu/project/id/101138959 |
| Start date: | 01-02-2024 |
| End date: | 31-07-2025 |
| Total budget - Public funding: | - 150 000,00 Euro |
Cordis data
Original description
"Beside Bacteria and fungi, Archaea, the ""third domain of life"" have been described as a stable component of the human microbiome. Yet, only few archaea have so far been isolated from humans.The project aims to demonstrate that a fundamentally new product, derived from archaea, revolutionizing current standards of treatments for human health, can be developed from our initial breakthrough achievement, the cultivation of these archaea. The benefits of using archaea derived from human bodies, promise a sustainable, safe and beneficial treatment in the future."
Status
SIGNEDCall topic
ERC-2023-POCUpdate Date
12-03-2024
Images
No images available.
Geographical location(s)
